Page last updated: 2024-11-03

probenecid and Leg Ulcer

probenecid has been researched along with Leg Ulcer in 1 studies

Probenecid: The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy.
probenecid : A sulfonamide in which the nitrogen of 4-sulfamoylbenzoic acid is substituted with two propyl groups.

Leg Ulcer: Ulceration of the skin and underlying structures of the lower extremity. About 90% of the cases are due to venous insufficiency (VARICOSE ULCER), 5% to arterial disease, and the remaining 5% to other causes.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ceilley, RI1

Other Studies

1 other study available for probenecid and Leg Ulcer

ArticleYear
Foot ulceration and vertebral osteomyelitis with Corynebacterium haemolyticum.
    Archives of dermatology, 1977, Volume: 113, Issue:5

    Topics: Aged; Ampicillin; Corynebacterium Infections; Diabetes Complications; Female; Humans; Leg Ulcer; Ost

1977